Author:
Higashi Daijiro,Irie Hisatoshi,Maki Toshimitsu,Kusaba Hiroshi,Koreeda Nobuhiko,Hirano Yosuke,Kaida Hiroki,Kawamoto Makoto,Komono Akira,Takahashi Hiroyuki,Sakamoto Rohei,Shibata Ryosuke,Miyasaka Yoshihiro,Hisabe Takashi,Nimura Satoshi,Watanabe Masato
Publisher
Springer Science and Business Media LLC
Reference19 articles.
1. Yano Y, Matsui T, Hirai F, Okado Y, Sato Y, Tsurumi K, et al. Cancer risk in Japanese Crohn’s disease patients: investigation of the standardized incidence ratio. J Gastroenterol Hepatol. 2013;28:1300–5.
2. Mizushima T, Ohno Y, Nakajima K, Kai Y, Iijima H, Sekimoto M, et al. Malignancy in Crohn’s disease: incidence and clinical characteristics in Japan. Digestion. 2010;81:265–70.
3. Korelitz BI. Carcinoma of the intestinal tract in Crohn’s disease: results of survey conducted by the National Foundation for Ileitis and colitis. Am J Gastroenterol. 1983;78:44–6.
4. Gyde SN, Prior P, Macartney JC, Thompson H, Waterhouse JA, Allan RN. Malignancy in Crohn’s disease. Gut. 1980;21:1024–9.
5. Von Roon AC, Reese G, Teare J, Constantinides V, Darzi AW, Tekkis PP. The risk of cancer in patients with Crohn’s disease. Dis Colon Rectum. 2007;50:839–55.